Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nightstar Therapeutics plc - American Depositary Shares (NY:NITE)

24.27 -1.30 (-5.07%)
Official Closing Price Updated: 8:00 PM EDT, Apr 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,759
Open 24.95
Bid (Size) 12.02 (1)
Ask (Size) 36.06 (1)
Prev. Close 25.57
Today's Range 24.27 - 24.95
52wk Range 22.21 - 31.89
Shares Outstanding 33,536,214
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Target Unveils $15 Billion Sales Growth Strategy With Focus on Digital Expansion
Target plans to drive $15B in sales growth by 2030 by expanding product categories, digital marketplace, owned brands, stores, loyalty program, and same-day services. 
Via Benzinga
Tesla's Sharp Drop Sends Shockwaves Through These ETFs
Tesla's stock decline is impacting ETFs with significant exposure to the company. Leveraged ETFs have been hit the hardest, while broad-market and sector ETFs are also experiencing losses. 
Via Benzinga
Topics ETFs

Performance

YTD
-17.2%
-17.2%
1 Month
-7.5%
-7.5%
3 Month
-18.0%
-18.0%
6 Month
-7.7%
-7.7%
1 Year
-2.4%
-2.4%

More News

Read More
Alibaba Jumps Post Q3 Earnings: ETFs To Buy
Via Talk Markets
Topics ETFs Stocks / Equities
Tesla Slips On Q4 Delivery Miss: ETFs In Focus
Via Talk Markets
Topics ETFs
BlackRock Makes $12 Billion Power Move - Agrees To Acquire HPS To Bolster Private Credit Offerings
Via Benzinga
Wynn Resorts' Q3 Performance Misses Expectations Amid Strategic Investments
Via Benzinga
BlackRock In Talks To Deepen Ties With Mukesh Ambani For Private Credit Venture
Via Benzinga
BlackRock's Steady Climb: Q3 Earnings Beat Projections, Assets Under Management Soars To $11.5T
Via Benzinga
Topics Earnings
Exposures Financial
Wynn Resorts' New York Casino Bid Could Act As A Positive Catalyst: Analyst
Via Benzinga
Elon Musk To Be Summoned By UK Parliament Over Role of Social Media Platform X
Via Benzinga
Trump Plans To Appoint Elon Musk To Government Efficiency Commission If Elected, Tesla CEO Says He'll Do It For Free
Via Benzinga
Topics Government
Exposures Political
Hyatt Expands Its Empire: Inks Deal To Bring Standard Hotels Under Its Wing
Via Benzinga
BlackRock Sells $2.5B In Bonds To Help Fund Preqin Deal: Report
Via Benzinga
Topics Bonds
Exposures Debt Markets
BlackRock's Aladdin Gets Smarter: $3.2B Deal Adds Preqin's Private Markets Data
Via Benzinga

Frequently Asked Questions

Is Nightstar Therapeutics plc - American Depositary Shares publicly traded?
Yes, Nightstar Therapeutics plc - American Depositary Shares is publicly traded.
What exchange does Nightstar Therapeutics plc - American Depositary Shares trade on?
Nightstar Therapeutics plc - American Depositary Shares trades on the New York Stock Exchange
What is the ticker symbol for Nightstar Therapeutics plc - American Depositary Shares?
The ticker symbol for Nightstar Therapeutics plc - American Depositary Shares is NITE on the New York Stock Exchange
What is the current price of Nightstar Therapeutics plc - American Depositary Shares?
The current price of Nightstar Therapeutics plc - American Depositary Shares is 24.27
When was Nightstar Therapeutics plc - American Depositary Shares last traded?
The last trade of Nightstar Therapeutics plc - American Depositary Shares was at 04/10/25 08:00 PM ET
What is the market capitalization of Nightstar Therapeutics plc - American Depositary Shares?
The market capitalization of Nightstar Therapeutics plc - American Depositary Shares is 813.99M
How many shares of Nightstar Therapeutics plc - American Depositary Shares are outstanding?
Nightstar Therapeutics plc - American Depositary Shares has 814M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.